Complete Left-Atrial Lesion Set versus Pulmonary Vein Isolation Only in Patients with Paroxysmal AF Undergoing CABG or AVR

• Published in: Medicina (Kaunas, Lithuania) Lithuania), 2022-11, Vol.58 (11), p.1607
• Main Authors: Yildirim, Yalin, Petersen, Johannes, Aydin, Ali, Alassar, Yousuf, Reichenspurner, Hermann, Pecha, Simon
• Format: Article
• Language: English
• Subjects: Ablation; arrhythmia surgery; Atrial Fibrillation; Care and treatment; Catheter Ablation - adverse effects; Catheters; Coronary Artery Bypass; Coronary vessels; Data analysis; Health aspects; Heart Atria - surgery; Heart surgery; Heart valve replacement; Humans; left-atrial ablation; Mortality; Patient outcomes; Patients; pulmonary vein isolation; Pulmonary veins; Pulmonary Veins - surgery; Questioning; Recurrence; Stroke; Stroke - complications; surgical ablation; Treatment Outcome; Veins & arteries
• ISSN: 1648-9144; 1010-660X; 1648-9144
• DOI: 10.3390/medicina58111607

: In patients with paroxysmal atrial fibrillation (AF) undergoing CABG or aortic valve surgery, many surgeons are not willing to open the left atrium to perform a complete left-sided Cox-Maze lesion set. Pulmonary vein isolation (PVI) is often favored in those patients. We investigated the outcome of patients with isolated pulmonary vein isolation compared to those receiving an extended left atrial (LA) lesion set. : Between 2003 and 2016, 817 patients received concomitant surgical AF ablation in our institution. A total of 268 patients with paroxysmal AF were treated by surgical ablation concomitant to AVR or CABG. Of those, 86 patients underwent a complete left-sided lesion set, while 182 patients were treated with an isolated pulmonary vein isolation. The primary endpoint was freedom from atrial fibrillation at 12 months' follow-up. There were no statistically significant differences regarding baseline characteristics. No major ablation-related complications were observed in any of the groups. In the PVI group, three patients (1.6%) had an intraoperative stroke, while two (2.3%) patients experienced a stroke in the LA ablation group ( = 0.98). In-hospital mortality was 3.4% in the PVI group, and 2.8% in the extended LA group ( = 0.33). Freedom from AF at 12 months' follow-up was 76% in the extended LA ablation group and 70% in the PVI group, showing no statistically significant difference ( = 0.32). Surgical AF ablation concomitant to CABG or AVR in patients with paroxysmal AF is safe and effective. There was no statistically significant difference between the compared lesion sets in terms of freedom from AF, survival or stroke rate after 12 months.